Literature DB >> 30837807

Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety.

Michael Rieder.   

Abstract

An underappreciated problem in child health is the risk for adverse drug reactions (ADRs). While there is an impression that children are at a lower risk than adults for ADRs, in fact a number of factors germane to pediatric therapy place certain groups of children at a high risk for adverse events associated with therapy. Given the importance of drug safety, an understanding of a diagnostic classification for ADRs and of how to approach a possible ADR clinically are key skills for pediatric pharmacists. As drug therapy for children evolves, becomes more complex, and begins to use novel molecules and biologicals there will be an increasing need for pediatric pharmacists to be more involved in clinical care, education, and research specific to drug safety.

Entities:  

Year:  2019        PMID: 30837807      PMCID: PMC6397008          DOI: 10.5863/1551-6776-24.1.4

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  42 in total

1.  An update on the therapeutic orphan.

Authors:  J T Wilson
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

2.  Adverse drug reactions: definitions, diagnosis, and management.

Authors:  I R Edwards; J K Aronson
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

3.  Frequency of adverse drug reactions in children: a prospective study.

Authors:  Annie Pierre Jonville-Béra; Bruno Giraudeau; Pascal Blanc; Frèdèrique Beau-Salinas; Elisabeth Autret-Leca
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

4.  Risk versus benefit considerations for the beta(2)-agonists.

Authors:  H William Kelly
Journal:  Pharmacotherapy       Date:  2006-09       Impact factor: 4.705

5.  A prospective study of adverse drug reactions in hospitalized children.

Authors:  I Martínez-Mir; M García-López; V Palop; J M Ferrer; E Rubio; F J Morales-Olivas
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 6.  Ontogeny of drug elimination by the human kidney.

Authors:  Nancy Chen; Katarina Aleksa; Cindy Woodland; Michael Rieder; Gideon Koren
Journal:  Pediatr Nephrol       Date:  2005-12-06       Impact factor: 3.714

Review 7.  Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.

Authors:  P Impicciatore; I Choonara; A Clarkson; D Provasi; C Pandolfini; M Bonati
Journal:  Br J Clin Pharmacol       Date:  2001-07       Impact factor: 4.335

8.  Predictors of Lamotrigine-associated rash.

Authors:  Lawrence J Hirsch; David B Weintraub; Richard Buchsbaum; Hilary T Spencer; Tara Straka; Melissa Hager; Stanley R Resor
Journal:  Epilepsia       Date:  2006-02       Impact factor: 5.864

Review 9.  Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Authors:  Gregory L Kearns; Susan M Abdel-Rahman; Sarah W Alander; Douglas L Blowey; J Steven Leeder; Ralph E Kauffman
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

Review 10.  Children versus adults: pharmacokinetic and adverse-effect differences.

Authors:  Gail D Anderson
Journal:  Epilepsia       Date:  2002       Impact factor: 5.864

View more
  7 in total

1.  Causality and avoidability of adverse drug reactions of antibiotics in hospitalized children: a cohort study.

Authors:  Sheila Feitosa Ramos; Fernando de Castro Araújo-Neto; Giulyane Targino Aires-Moreno; Dyego Carlos Souza Anacleto de Araújo; Elisângela da Costa Lima; Divaldo Pereira de Lyra
Journal:  Int J Clin Pharm       Date:  2021-03-03

2.  Evaluation and Implementation of KIDs List Recommendations in a University Health System.

Authors:  Victoria H Anderson; Jordan Anderson; Sarah Durham; Erin Collard
Journal:  J Pediatr Pharmacol Ther       Date:  2022-09-26

3.  Improving Patient-Pharmacist Encounters with Over-The-Counter Medications: A Mixed-Methods Pilot Study.

Authors:  Aaron M Gilson; Ka Z Xiong; Jamie A Stone; Nora Jacobson; Cynthia Phelan; Apoorva Reddy; Michelle A Chui
Journal:  Innov Pharm       Date:  2020-02-14

4.  Drug Allergy in Children: What Should We Know?

Authors:  Ji Soo Park; Dong In Suh
Journal:  Clin Exp Pediatr       Date:  2019-11-12

5.  Utilization of the Naranjo scale to evaluate adverse drug reactions at a free-standing children's hospital.

Authors:  Madhavi Murali; Sarah L Suppes; Keith Feldman; Jennifer L Goldman
Journal:  PLoS One       Date:  2021-01-13       Impact factor: 3.240

6.  Methodologic Progress Note: Opportunistic Sampling for Pharmacology Studies in Hospitalized Children.

Authors:  Sonya Tang Girdwood; Jennifer Kaplan; Alexander A Vinks
Journal:  J Hosp Med       Date:  2021-01       Impact factor: 2.960

7.  Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.

Authors:  Iris Cohn; Roozbeh Manshaei; Eriskay Liston; John B A Okello; Reem Khan; Meredith R Curtis; Abby J Krupski; Rebekah K Jobling; Kelsey Kalbfleisch; Tara A Paton; Miriam S Reuter; Robin Z Hayeems; Ruud H J Verstegen; Aaron Goldman; Raymond H Kim; Shinya Ito
Journal:  JAMA Netw Open       Date:  2021-05-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.